Novartis CEO discusses how AI will impact drug development Published 2024-01-17 Download video MP4 360p Recommendations 26:11 How AI Could Transform Drug Development And The Life Sciences 24:07 Novartis CEO Vas Narasimhan on The David Rubenstein Show 13:46 Pfizer is 'deeply sorry' 11:50 Novartis ‘focusing on high-end, innovative medicines,’ CEO says 45:49 The Possibilities of AI [Entire Talk] - Sam Altman (OpenAI) 20:35 Novartis Strategy & Growth Update 06:53 Verizon CEO on the impact of generative AI on wireless networks 55:49 Introduction to AI in Drug Discovery 17:58 How AI is Used in Pharma and Healthcare for Clinical Drug Development - James Cai, Roche 42:52 Beyond the Hype: A Realistic Look at Large Language Models • Jodie Burchell • GOTO 2024 43:50 Vasant Narasimhan, Chief Executive Officer, Novartis | BSR18 32:27 How AI is Revolutionizing Drug Development with Prof. Yaakov Nahmias | WIRED Briefings 32:00 Why Thorium will be a Game-Changer in Energy 51:15 Generative AI in Drug Discovery and Pharma, with Insilico Medicine (CXOTalk #782) 25:17 Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company 29:24 2018 WMIF | 1:1 Fireside Chat: Vasant Narasimhan, MD, CEO, Novartis 1:05:34 Artificial Intelligence in Drug Discovery & Development 16:56 Reimagining Drug Discovery and Medicine: Protein Folding and the Next Technological Revolution 36:44 Generative AI in Biology and Healthcare | GTC 2023 Similar videos 23:37 Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19 07:22 Drug discovery and development process 44:23 Data Science, Predictive Analytics, and AI in Drug Discovery with Novartis (CXOTalk #717) 07:51 Watch CNBC's full interview with Novartis CEO Vas Narasimhan 52:51 Integrating AI for Revolutionary Drug Development and Discovery @ Novartis 36:22 The Future of AI in the Healthcare Pharmaceutical Industry with Merck, Novartis, AstraZeneca 04:22 Novartis CEO on new cancer therapy programs 49:11 2018 WMIF | Drug Therapy Redefined Through Machine Learning 04:11 Novartis CEO on ESG: Pandemic has been a reset for pharma's reputation 01:45 The promise of precision medicine 16:04 Reducing Risk in Drug Development through AI, Physics, and Cloud Computing 21:03 The Future of Human Health: Panel discussion 02:50 Democratizing access to AI 03:33 Novartis starts strategic review of Sandoz generic drug unit: CEO 01:40 Novartis + Microsoft reimagining medicine using AI More results